Capital Advisory Group Advisory Services’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-138
Closed -$6K 242
2022
Q1
$6K Buy
+138
New +$6.12K ﹤0.01% 411
2021
Q4
Sell
-138
Closed -$7K 208
2021
Q3
$7K Hold
138
﹤0.01% 429
2021
Q2
$7K Hold
138
﹤0.01% 428
2021
Q1
$6K Hold
138
﹤0.01% 429
2020
Q4
$7K Hold
138
﹤0.01% 399
2020
Q3
$6K Hold
138
﹤0.01% 360
2020
Q2
$6K Hold
138
﹤0.01% 350
2020
Q1
$5K Buy
+138
New +$5.5K 0.01% 301
2019
Q4
Sell
-252
Closed -$9K 221
2019
Q3
$9K Hold
252
0.01% 288
2019
Q2
$9K Hold
252
0.01% 285
2019
Q1
$10K Hold
252
0.01% 274
2018
Q4
$9K Hold
252
0.01% 252
2018
Q3
$11K Hold
252
0.01% 238
2018
Q2
$9K Hold
252
0.01% 239
2018
Q1
$9K Buy
+252
New +$8.97K 0.01% 231

Other funds holding BME

Capital Advisory Group Advisory Services's BME Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of BlackRock Health Sciences Trust (BME) in Q2 2022, closing a stake of 138 shares — an estimated $6K sold.

Capital Advisory Group Advisory Services first reported a position in BME in Q1 2018 and held it in 15 quarters. The position peaked at $11K in Q3 2018. 62 funds tracked by Wall St. Rank hold BME as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining BlackRock Health Sciences Trust position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 138 BlackRock Health Sciences Trust shares in Q2 2022, an estimated $6K.
  • Capital Advisory Group Advisory Services first reported a position in BlackRock Health Sciences Trust in Q1 2018 and held it in 15 quarters.
  • Capital Advisory Group Advisory Services's BlackRock Health Sciences Trust position peaked at $11K in Q3 2018.
  • 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.